Zepbound (tirzepatide) is a once-weekly injectable prescription medication that, like Mounjaro, targets both GLP-1 and GIP receptors to help reduce appetite and support significant weight loss. Zepbound and Mounjaro share the same active ingredient, tirzepatide, though they are marketed under different brand names. Clinical trial data has shown average weight loss of up to around 20% of body weight when tirzepatide is combined with a reduced-calorie diet and increased physical activity.
Browse our range of Zepbound pen strengths below. Before starting treatment, every patient completes a full clinical assessment with one of our UK-registered prescribers, who will review your medical history and confirm that Zepbound is a suitable and safe option for you. Your dose is introduced gradually and monitored closely to help manage side effects and support steady progress.
Our clinical team is available throughout your treatment to answer questions about starting Zepbound, adjusting your dose, and combining medication with sustainable lifestyle changes.
Showing the single result
